Home/Filings/4/0000950170-25-090944
4//SEC Filing

Dadoo Rajeev 4

Accession 0000950170-25-090944

CIK 0001671858other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 4:43 PM ET

Size

5.4 KB

Accession

0000950170-25-090944

Insider Transaction Report

Form 4
Period: 2025-06-25
Dadoo Rajeev
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-25+30,00030,000 total
    Exercise: $17.26Exp: 2035-06-24Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.

Documents

1 file

Issuer

ARS Pharmaceuticals, Inc.

CIK 0001671858

Entity typeother

Related Parties

1
  • filerCIK 0001951685

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:43 PM ET
Size
5.4 KB